Register Login

ANI PHARMACEUTICALS INC (ANIP)

SymbolANIP
NameANI PHARMACEUTICALS INC
SectorHEALTH CARE
RegionUNDEFINED
IndustryPharmaceutical Preparations
Address210 MAIN STREET WEST, BAUDETTE, MN 56623
Telephone2186343500
Fax—
Email—
Websitehttps://www.anipharmaceuticals.com
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK—
Description

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Flecainide, Fluvoxamine, Hydrocortisone Enema, Methazolamide, Metoclopramide Syrup Nilutamide, Propafenone, and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Additional info from NASDAQ:
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Flecainide, Fluvoxamine, Hydrocortisone Enema, Methazolamide, Metoclopramide Syrup Nilutamide, Propafenone, and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

2026-04-24 10:50

ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ET

Read more
2026-04-20 10:50

ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity

Read more
2026-04-13 20:40

Cook Meredith 🔴 sold 500 shares of ANI PHARMACEUTICALS INC (ANIP) at $77.95 Transaction Date: Apr 13, 2026 | Filing ID: 000013

Read more
2026-04-13 10:50

ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules

Read more
2026-04-09 17:15

New Form ARS - ANI PHARMACEUTICALS INC <b>Filed:</b> 2026-04-09 <b>AccNo:</b> 0001023024-26-000041 <b>Size:</b> 22 MB

Read more
2026-04-09 17:13

New Form DEFA14A - ANI PHARMACEUTICALS INC <b>Filed:</b> 2026-04-09 <b>AccNo:</b> 0001023024-26-000040 <b>Size:</b> 1 MB

Read more
2026-04-09 17:12

New Form DEF 14A - ANI PHARMACEUTICALS INC <b>Filed:</b> 2026-04-09 <b>AccNo:</b> 0001023024-26-000039 <b>Size:</b> 5 MB

Read more
2026-04-08 10:50

ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet

Read more
2026-04-07 10:50

ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology

Read more
2026-03-26 16:46

New Form SCHEDULE 13G/A - ANI PHARMACEUTICALS INC <b>Filed:</b> 2026-03-26 <b>AccNo:</b> 0000102909-26-000694 <b>Size:</b> 7 KB

Read more
Trial ID Title Phase Indication Status Start Date Completion Date Source
NCT00633373 Cyclosporine Inhalation Solution (CIS) in Lung Transplant Recipients — Lung Transplant No_Longer_Available — — ClinicalTrials.gov
NCT07204080 (TNX-1500) in Kidney Transplant Recipients Phase2 Kidney Transplant Not_Yet_Recruiting 2026-07-01 2029-06-30 ClinicalTrials.gov
NCT07365904 Investigating Ovulation Inhibition for Use as a Contraceptive Phase2 Contraception Recruiting 2025-12-22 2026-11-30 ClinicalTrials.gov
NCT07346079 Purified Cortrophin® Gel Efficacy and Safety Study of 2 Dose Levels in Patients… Phase4 Gout Arthritis Recruiting 2025-12-20 2027-08-31 ClinicalTrials.gov
NCT07413367 A Phase 1, Open-Label, Parallel-Group, Single-Dose Study To Compare The Pharmak… Phase1 Pharmakokinetic Active_Not_Recruiting 2025-12-09 2026-02-10 ClinicalTrials.gov
NCT04789148 Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency Phase1 Vasopressin Deficiency Recruiting 2025-09-10 2026-06-01 ClinicalTrials.gov
NCT06866275 Suramin for the Treatment of Autism Trial: KZ101 in a Male Pediatric Population… Phase2 Autism Spectrum Disorder (ASD) Recruiting 2025-04-09 2028-04-01 ClinicalTrials.gov
NCT06813807 A Comparative Study of the Pharmacokinetic Profiles of Timolol Maleate Ophthalm… Phase1 Healthy Subjects Completed 2024-06-15 2024-07-05 ClinicalTrials.gov
NCT06048536 Dose-finding Study of MR-130A-01 Contraceptive Transdermal Patch Phase2 Contraception Completed 2023-12-22 2024-01-18 ClinicalTrials.gov
NCT06136884 A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in… Phase1 Solid Tumor Malignancies Recruiting 2023-11-02 2028-01-27 ClinicalTrials.gov
NCT05686408 Study to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major … Phase2 Depression Completed 2023-03-02 2023-09-29 ClinicalTrials.gov
NCT05486468 The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intrao… Phase3 Uveitis Recruiting 2022-10-05 2026-12-01 ClinicalTrials.gov
NCT05472090 A Phase 2 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Patients W… Phase2 Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection Completed 2022-08-18 2023-07-27 ClinicalTrials.gov
NCT05273749 A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily i… Phase3 Fibromyalgia Completed 2022-04-06 2023-11-14 ClinicalTrials.gov
NCT06955650 First-in-man Imaging of a New PET Radiotracer for Oxytocin Receptors Early_Phase1 Pain, Face Completed 2021-04-30 2022-06-30 ClinicalTrials.gov
NCT04655170 Feasibility, Safety and Efficacy of Nebulized Long-Acting Bronchodilators (Form… Phase4 COPD Exacerbation Unknown 2020-12-09 2023-03-30 ClinicalTrials.gov
NCT06677853 Timolol Maleate Gel for the Treatment of Infantile Hemangioma Phase2 Infantile Hemangioma Completed 2020-10-28 2022-06-21 ClinicalTrials.gov
NCT04508621 A Phase 3 Study To Evaluate The Efficacy And Safety Of TNX-102 SL In Patients W… Phase3 Fibromyalgia Completed 2020-07-22 2021-11-01 ClinicalTrials.gov
NCT04172831 A Study To Evaluate The Efficacy And Safety Of TNX-102 SL In Patients With Fibr… Phase3 Fibromyalgia Completed 2019-12-09 2020-10-29 ClinicalTrials.gov
NCT04164719 Dose-Proportionality and Food Effect Study of TNX-102 SL Phase1 Healthy Subjects Completed 2019-10-14 2019-12-24 ClinicalTrials.gov
NCT03841773 A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Participan… Phase3 PTSD Terminated 2019-03-07 2020-04-24 ClinicalTrials.gov
NCT03610646 Comparative Study to Evaluate the Efficacy and Safety of MYL-1701P and Eylea® i… Phase3 Diabetic Macular Edema Completed 2018-08-23 2021-09-10 ClinicalTrials.gov
NCT03000595 A Trial of a Botanical Drug Product Containing East Indian Sandalwood Oil (EISO… Phase2 Atopic Dermatitis Withdrawn 2018-06-01 2019-01-01 ClinicalTrials.gov
NCT03443960 Steady-State Pharmacokinetic Comparison Study of TNX-102 SL 5.6 mg Versus AMRIX… Phase1 Healthy Subjects Completed 2018-01-29 2018-04-09 ClinicalTrials.gov
NCT02871479 A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) For Tr… Phase2 Atopic Dermatitis Completed 2017-04-21 2018-08-31 ClinicalTrials.gov
NCT04633564 MYL-1402O Compared With Avastin®, in Patients With Stage IV nsNSCLC Phase3 NSCLC Stage IV Completed 2017-01-21 2019-11-22 ClinicalTrials.gov
NCT02829814 Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tab… Phase3 Fibromyalgia Terminated 2016-07-22 2016-09-13 ClinicalTrials.gov
NCT02589275 A 3-Month Open-Label Safety and Efficacy Study of TNX-102 SL Tablets in Fibromy… Phase3 Primary Fibromyalgia Completed 2015-08-04 2016-09-28 ClinicalTrials.gov
NCT02438007 A Study of Galeterone Compared to Enzalutamide In Men Expressing Androgen Recep… Phase3 Prostate Cancer Terminated 2015-06-01 2016-11-01 ClinicalTrials.gov
NCT02436096 A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken a… Phase3 Fibromyalgia Completed 2015-04-01 2016-09-01 ClinicalTrials.gov
NCT02195986 A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal… Phase3 Atrophic Vaginitis Completed 2014-06-01 2014-12-01 ClinicalTrials.gov
NCT02082054 StahistRx Phase 2, Five-arm, Parallel Group, Active vs Active, Double-blind Stu… Phase2 Rhinitis, Seasonal, Allergic Unknown 2014-03-01 2014-05-01 ClinicalTrials.gov
NCT02015234 12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgi… Phase3 Primary Fibromyalgia Completed 2013-12-01 2015-08-01 ClinicalTrials.gov
NCT01903265 BEdtime Sublingual TNX-102 SL as Fibromyalgia Intervention Therapy (BESTFIT) Phase2 Primary Fibromyalgia Completed 2013-09-01 2014-09-01 ClinicalTrials.gov
NCT02594761 Phase 1 Study of Trastuzumab Administered as a Single Intravenous Infusion Phase1 Healthy Completed 2013-08-01 2014-02-01 ClinicalTrials.gov
NCT01889173 Comparative Pharmacokinetics and Safety of 3 Different Formulations of TNX-102 … Phase1 Healthy Adults Completed 2013-06-01 2014-03-01 ClinicalTrials.gov
NCT01709734 A 2 Part, Phase 2 Trial of Galeterone in the Treatment of Castration Resistant … Phase2 Prostate Cancer Terminated 2012-12-01 2016-09-01 ClinicalTrials.gov
NCT01689259 Comparative Pharmacokinetics and Safety of TNX-102 SL Tablets and Cyclobenzapri… Phase1 Healthy Adults Completed 2012-09-01 2014-03-01 ClinicalTrials.gov
NCT01634412 Comparative Bioavailability of Sublingual TNX-102, Oral and Intravenous Cyclobe… Phase1 Healthy Adults Completed 2012-06-01 2014-01-01 ClinicalTrials.gov
NCT01490788 A Comparative Bioavailability and Pharmacokinetic Study of TNX-102 2.4 mg and C… Phase1 Healthy Completed 2011-11-18 2011-12-30 ClinicalTrials.gov
NCT01008397 Study of AHIST in Seasonal Allergic Rhinitis Patients Phase1 Rhinitis, Allergic, Seasonal Withdrawn 2011-04-01 2011-05-01 ClinicalTrials.gov
NCT01293201 Trial of STAHIST in Seasonal Allergic Rhinitis Phase3 Seasonal Allergic Rhinitis Completed 2011-03-01 2011-08-01 ClinicalTrials.gov
NCT01171664 Clinical Trial of STAHIST in Seasonal Allergic Rhinitis (SAR) Subjects Phase2 Seasonal Allergic Rhinitis Completed 2010-09-01 2011-01-01 ClinicalTrials.gov
NCT00938236 CIS001 Extension Study of Cyclosporine Inhalation Solution Phase3 Lung Transplant Terminated 2009-12-01 2011-12-01 ClinicalTrials.gov
NCT00932256 Clinical Trial of STAHIST in Seasonal Allergic Rhinitis Patients Phase1 Rhinitis, Allergic, Seasonal Completed 2009-10-01 2010-12-01 ClinicalTrials.gov
NCT01184391 Bioequivalence Study of Divalproex Sodium Delayed-Release Tablets, 500 mg Phase1 Healthy Completed 2007-07-01 2007-08-01 ClinicalTrials.gov
NCT00647959 Fasting Study of Doxycycline Monohydrate Tablets 150 mg and Adoxa Tablets 150 mg Phase1 Healthy Completed 2006-03-01 2006-04-01 ClinicalTrials.gov
NCT00649636 Fasting Study of Fluoxetine Capsules 40 mg and Prozac Pulvules 40 mg Phase1 Healthy Completed 2006-02-01 2006-04-01 ClinicalTrials.gov
NCT00648401 Food Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Ex… Phase1 Healthy Completed 2006-01-01 2006-02-01 ClinicalTrials.gov
NCT00649272 Fasting Study of Oxybutynin Chloride Extended-Release Tablets 15 mg and Ditropa… Phase1 Healthy Completed 2006-01-01 2006-02-01 ClinicalTrials.gov
NCT00649805 Fasting Applesauce Study of Verapamil HCl Extended-Release Capsules 300 mg and … Phase1 Healthy Completed 2006-01-01 2006-02-01 ClinicalTrials.gov
NCT00647621 Steady-State Study of Extended Phenytoin Sodium Capsules 100 mg and Dilantin® K… Phase1 Healthy Completed 2005-10-01 2005-12-01 ClinicalTrials.gov
NCT00647816 Fasting Study of Propranolol Hydrochloride Extended-Release Capsules 160 mg and… Phase1 Healthy Completed 2005-09-01 2005-09-01 ClinicalTrials.gov
NCT00649987 Fed Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Ta… Phase1 Healthy Completed 2005-09-01 2005-10-01 ClinicalTrials.gov
NCT00648700 Fasting Study of Levothyroxine Sodium Tablets 300 μg to Levothroid® Tablets 300… Phase1 Healthy Completed 2005-08-01 2005-09-01 ClinicalTrials.gov
NCT00649571 Fasting Study of Doxycycline Monohydrate Tablets 100 mg and Adoxa Tablets 100 mg Phase1 Healthy Completed 2005-07-01 2005-07-01 ClinicalTrials.gov
NCT00649363 Fasting Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® … Phase1 Healthy Completed 2005-07-01 2005-07-01 ClinicalTrials.gov
NCT00648804 Food Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® Tab… Phase1 Healthy Completed 2005-07-01 2005-07-01 ClinicalTrials.gov
NCT00649454 Fasting Study of Glipizide and Metformin HCl Tablets 5 mg/500 mg to Metaglip® T… Phase1 Healthy Completed 2005-06-01 2005-06-01 ClinicalTrials.gov
NCT00648427 Fasting Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to P… Phase1 Healthy Completed 2005-04-01 2005-05-01 ClinicalTrials.gov
NCT00650273 Fasting Study of Azithromycin Tablets 600 mg to Zithromax® Tablets 600 mg Phase1 Healthy Completed 2005-04-01 2005-05-01 ClinicalTrials.gov
NCT00647894 Fasting Study of Alprazolam Extended-Release Tablets 1 mg to Xanax XR Tablets 1… Phase1 Healthy Completed 2005-01-01 2005-01-01 ClinicalTrials.gov
NCT00649818 Fasting Study of Lorazepam Tablets 2 mg and Ativan Tablets 2 mg Phase1 Healthy Completed 2004-12-01 2004-12-01 ClinicalTrials.gov
NCT00650169 Food Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mg Phase1 Healthy Completed 2004-12-01 2005-01-01 ClinicalTrials.gov
NCT00648362 Fasting Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg Phase1 Healthy Completed 2004-11-01 2004-12-01 ClinicalTrials.gov
NCT00648791 Fasting Study of Finasteride Tablets 5 mg and Proscar Tablets 5 mg Phase1 Healthy Completed 2004-09-01 2004-10-01 ClinicalTrials.gov
NCT00648661 Food Study of Escitalopram Oxalate Tablets 20 mg to Lexapro® Tablets 20 mg Phase1 Healthy Completed 2004-09-01 2004-10-01 ClinicalTrials.gov
NCT00650299 Fed Study of Alprazolam Extended-release Tablets 3 mg to Xanax XR® Tablets 3 mg Phase1 Healthy Completed 2004-08-01 2004-08-01 ClinicalTrials.gov
NCT00647634 Fasting Study of Alprazolam Extended-Release Tablets 3 mg to Xanax XR® Tablets … Phase1 Healthy Completed 2004-08-01 2004-08-01 ClinicalTrials.gov
NCT00647751 Food Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mg Phase1 Healthy Completed 2004-08-01 2004-08-01 ClinicalTrials.gov
NCT00649077 Fasting Study of Meloxicam Tablets 15 mg and Mobic® Tablets 15 mg Phase1 Healthy Completed 2004-08-01 2004-09-01 ClinicalTrials.gov
NCT00649675 Food Study of Meloxicam Tablets 15 mg and Mobic® Tablets 15 mg Phase1 Healthy Completed 2004-08-01 2004-09-01 ClinicalTrials.gov
NCT00650208 Fasting Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mg Phase1 Healthy Completed 2004-07-01 2004-08-01 ClinicalTrials.gov
NCT00649402 Fed Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Caps… Phase1 Healhty Completed 2004-05-01 2004-06-01 ClinicalTrials.gov
NCT00649519 Fasting Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® … Phase1 Healthy Completed 2004-05-01 2004-05-01 ClinicalTrials.gov
NCT00648531 Fasting Study of Balsalazide Disodium Capsules 750 mg and Colazal® Capsules 750… Phase1 Healthy Completed 2004-05-01 2004-05-01 ClinicalTrials.gov
NCT00648622 Fed Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mg Phase1 Healthy Completed 2004-04-01 2004-04-01 ClinicalTrials.gov
NCT00650195 Fasting Study of Metolazone Tablets 10 mg and Zaroloxyn® Tablets 10 mg Phase1 Healthy Completed 2004-02-01 2004-03-01 ClinicalTrials.gov
NCT00648518 Fasting Study of Metformin Hydrochloride ER Tablets 750 mg and Glucophage® XR T… Phase1 Healthy Completed 2003-12-01 2003-12-01 ClinicalTrials.gov
NCT00649350 Food Study Metformin Hydrochloride ER Tablets 750 mg and Glucophage XR 750 mg Phase1 Healthy Completed 2003-12-01 2003-12-01 ClinicalTrials.gov
NCT00648336 Fasting Study of Mercaptopurine 50 mg and Purinethol® Tablets 50 mg Phase1 Healthy Completed 2003-11-01 2003-12-01 ClinicalTrials.gov
NCT00647985 Food Study of Fexofenadine Tablets 180 mg and Allegra® Tablets 180 mg Phase1 Healthy Completed 2003-11-01 2003-11-01 ClinicalTrials.gov
NCT00649181 Fasting Study of Metolazone Tablets 5 mg and Zaroloxyn® Tablets 5 mg Phase1 Healthy Completed 2003-10-01 2003-11-01 ClinicalTrials.gov
NCT00647738 Comparative Bioavailability Study of Baclofen 20 mg Tablets in Healthy Male Vol… Phase1 Healthy Completed 2003-10-01 2003-11-01 ClinicalTrials.gov
NCT00649506 Food Study of Nitrofurantoin Macrocrystals 100 mg Capsules and Macrodantin® 100… Phase1 Healthy Completed 2003-09-01 2003-09-01 ClinicalTrials.gov
NCT00649441 Fasting Study of Quinapril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to A… Phase1 Healthy Completed 2003-08-01 2003-09-01 ClinicalTrials.gov
NCT00649194 Food Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Tabl… Phase1 Healthy Completed 2003-08-01 2003-08-01 ClinicalTrials.gov
NCT00649532 Fasting Study of Ondansetron Tablets 24 mg and Zofran® Tablets 24 mg Phase1 Healthy Completed 2003-07-01 2003-07-01 ClinicalTrials.gov
NCT00648544 Fed, Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol®… Phase1 Therapeutic Equivalency Completed 2003-07-01 2003-07-01 ClinicalTrials.gov
NCT00648583 Food Study of Ondansetron Tablets 24 mg and Zofran® Tablets 24 mg Phase1 Healthy Completed 2003-07-01 2003-07-01 ClinicalTrials.gov
NCT00650221 Fasting Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravach… Phase1 Therapeutic Equivalency Completed 2003-06-01 2003-07-01 ClinicalTrials.gov
NCT00647777 Food Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mg Phase1 Healthy Completed 2003-06-01 2003-07-01 ClinicalTrials.gov
NCT00648349 Fasting Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® D… Phase1 Healthy Completed 2003-05-01 2003-06-01 ClinicalTrials.gov
NCT00647855 Fasting Study of Levothyroxine Sodium Tablets 300 μg to Synthroid® Tablets 300 … Phase1 Healthy Completed 2003-05-01 2003-06-01 ClinicalTrials.gov
NCT00649012 Food Study of Pioglitazone HCl Tablets 45 mg to Actos® Tablets 45 mg Phase1 Healthy Completed 2003-03-01 2003-03-01 ClinicalTrials.gov
NCT00649558 Fasting Study of Pioglitazone HCl Tablets 45 mg and Actos® Tablets 45 mg Phase1 Healthy Completed 2003-02-01 2003-03-01 ClinicalTrials.gov
NCT00648778 Fasting Study of Loxapine Succinate Capsules 25 mg and Loxitane® Capsules 25 mg Phase1 Healthy Completed 2003-01-01 2003-02-01 ClinicalTrials.gov
NCT00648557 Fasting Study of Levothyroxine Sodium Tablets 200 mg to Synthroid Tablets 200 mg Phase1 Healthy Completed 2003-01-01 2003-03-01 ClinicalTrials.gov
NCT00649688 Fasting Study of Metoprolol Tartrate/Hydrochlorothiazide Tablets 100/50 mg and … Phase1 Healthy Completed 2003-01-01 2003-02-01 ClinicalTrials.gov
NCT00649233 Food Study of Metoprolol Tartrate/Hydrochlorothiazide Tablets 100/50 mg to Lopr… Phase1 Healthy Completed 2003-01-01 2003-02-01 ClinicalTrials.gov
NCT00649649 Food Study of Quinapril Hydrochloride Tablets 40 mg and Accupril® Tablets 40 mg Phase1 Healthy Completed 2002-12-01 2003-01-01 ClinicalTrials.gov
NCT00649051 Fasting Study of Metolazone Tablets 2.5 mg and Zaroloxyn® Tablets 2.5 mg Phase1 Healthy Completed 2002-12-01 2003-01-01 ClinicalTrials.gov
NCT00649038 Fed Study of Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Lote… Phase1 Healthy Completed 2002-12-01 2002-12-01 ClinicalTrials.gov
NCT00648843 Food Study of Oxybutynin Chloride Extended-release Tablets 5 mg and Ditropan XL… Phase1 Healthy Completed 2002-12-01 2003-01-01 ClinicalTrials.gov
NCT00648856 Food Study of Sertraline Hydrochloride Tablets 100 mg and Zoloft® Tablets 100 mg Phase1 Healthy Completed 2002-12-01 2003-01-01 ClinicalTrials.gov
NCT00650065 Fasting Study of Cetirizine HCl Tablets 10 mg and Zyrtec® Tablets 10 mg Phase1 Healthy Completed 2002-11-01 2002-12-01 ClinicalTrials.gov
NCT00649857 Food Study of Cetirizine HCl Tablets 10 mg and Zyrtec® 10 mg Phase1 Healthy Completed 2002-11-01 2002-12-01 ClinicalTrials.gov
NCT00650000 Fasting Study of Modafinil Tablets 200 mg and Provigil® Tablets 200 mg Phase1 Healthy Completed 2002-10-01 2002-10-01 ClinicalTrials.gov
NCT00648492 Food Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR 500 mg Phase1 Healthy Completed 2002-10-01 2002-11-01 ClinicalTrials.gov
NCT00649285 Food Study of Nitrofurantoin Monohydrate/Macrocrystals Capsules 100 mg and Macr… Phase1 Healthy Completed 2002-10-01 2002-11-01 ClinicalTrials.gov
NCT00650312 Fasting Study of Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR T… Phase1 Healthy Completed 2002-10-01 2002-11-01 ClinicalTrials.gov
NCT00650286 Food Study of Modafinil Tablets 200 mg to Provigil® Tablets 200 mg Phase1 Healthy Completed 2002-09-01 2002-10-01 ClinicalTrials.gov
NCT00649129 Fasting Study of Oxybutynin Chloride ER Tablets 10 mg and Ditropan XL® Tablets … Phase1 Healthy Completed 2002-07-01 2002-08-01 ClinicalTrials.gov
Total clinical trials: 113
Product Name Type Development Stage Therapeutic Area Study Status Trial ID
Placebo DRUG Phase PHASE2 Autism Spectrum Disorder (ASD) RECRUITING NCT06866275
KZ101 DRUG Phase PHASE2 Autism Spectrum Disorder (ASD) RECRUITING NCT06866275
DIVALPROEX SODIUM DELAYED-RELEASE TABLETS, USP, 500 MG DRUG Phase PHASE1 Healthy COMPLETED NCT01184391
DEPAKOTE® Tablets, 500 MG DRUG Phase PHASE1 Healthy COMPLETED NCT01184391
STAHIST NDC #58407-536-01 DRUG Phase PHASE1 Rhinitis, Allergic, Seasonal COMPLETED NCT00932256
Cyclosporine Inhalation Solution (CIS) DRUG Phase PHASE3 Lung Transplant TERMINATED NCT00938236
Cyclosporine Inhalation Solution DRUG Preclinical Lung Transplant NO_LONGER_AVAILABLE NCT00633373
AHIST NDC#58407-012-01 DRUG Phase PHASE1 Rhinitis, Allergic, Seasonal WITHDRAWN NCT01008397
STAHIST DRUG Phase PHASE3 Seasonal Allergic Rhinitis COMPLETED NCT01293201
Placebo Nasal Spray, 50 μL/actuation DRUG Phase PHASE1 Treatment of the Signs and Symptoms of Seasonal Allergic Rhinitis COMPLETED NCT02109185
Nasonex® Nasal Spray Suspnsn, 50 μg/actuation DRUG Phase PHASE1 Treatment of the Signs and Symptoms of Seasonal Allergic Rhinitis COMPLETED NCT02109185
Nasonex® Nasal Spray, 50 μg/actuation DRUG Phase PHASE1 Treatment of the Signs and Symptoms of Seasonal Allergic Rhinitis COMPLETED NCT02109185
Mometasone Furoate Monohydrate Nasal Spray, 50 μg/act. DRUG Phase PHASE1 Treatment of the Signs and Symptoms of Seasonal Allergic Rhinitis COMPLETED NCT02109185
Atropine 0.24 mg DRUG Phase PHASE2 Rhinitis, Seasonal, Allergic UNKNOWN NCT02082054
PSE 120 mg, CM 8 mg DRUG Phase PHASE2 Rhinitis, Seasonal, Allergic UNKNOWN NCT02082054
PSE 120 mg, CM 8 mg, Atr 0.12 mg DRUG Phase PHASE2 Rhinitis, Seasonal, Allergic UNKNOWN NCT02082054
PSE 120 mg, CM 8 mg, Atr 0.24 mg DRUG Phase PHASE2 Rhinitis, Seasonal, Allergic UNKNOWN NCT02082054
PSE 120 mg, CM 8 mg, Atr 0.36 mg DRUG Phase PHASE2 Rhinitis, Seasonal, Allergic UNKNOWN NCT02082054
TNX-102-C SL Tablets at 2.8 mg DRUG Phase PHASE1 Healthy Adults COMPLETED NCT01889173
TNX-102-B SL Tablets at 2.8 mg DRUG Phase PHASE1 Healthy Adults COMPLETED NCT01889173
TNX-102 SL Tablets at 2.8 mg DRUG Phase PHASE1 Healthy Adults COMPLETED NCT01889173
Cyclobenzaprine tablets DRUG Phase PHASE1 Healthy Adults COMPLETED NCT01889173
SL TNX-102-A at 2.4 mg DRUG Phase PHASE1 Healthy Adults COMPLETED NCT01689259
SL TNX-102 at 4.8 mg DRUG Phase PHASE1 Healthy Adults COMPLETED NCT01689259
SL TNX-102 at 2.4 mg DRUG Phase PHASE1 Healthy Adults COMPLETED NCT01689259
Cyclobenzaprine IV DRUG Phase PHASE1 Healthy Adults COMPLETED NCT01634412
Cyclobenzaprine Tablet DRUG Phase PHASE1 Healthy Adults COMPLETED NCT01634412
SL TNX-102 2.4 mg at pH 7.1 DRUG Phase PHASE1 Healthy Adults COMPLETED NCT01634412
SL TNX-102 2.4 mg at pH 3.5 DRUG Phase PHASE1 Healthy Adults COMPLETED NCT01634412
Herceptin US BIOLOGICAL Phase PHASE1 Healthy COMPLETED NCT02594761
Herceptin EU BIOLOGICAL Phase PHASE1 Healthy COMPLETED NCT02594761
Hercules BIOLOGICAL Phase PHASE1 Healthy COMPLETED NCT02594761
Racemic isometheptene 70 mg DRUG Phase PHASE1 Healthy COMPLETED NCT02290379
TNX-201 140 mg DRUG Phase PHASE1 Healthy COMPLETED NCT02290379
TNX-201 70 mg DRUG Phase PHASE1 Healthy COMPLETED NCT02290379
TNX-201 35 mg DRUG Phase PHASE1 Healthy COMPLETED NCT02290379
Placebo Capsule OTHER Phase PHASE1 Toxicity UNKNOWN NCT02778386
N-Methanocarbathymidine DRUG Phase PHASE1 Toxicity UNKNOWN NCT02778386
TNX-102 SL 2.8mg DRUG Phase PHASE2 Primary Fibromyalgia COMPLETED NCT01903265
Amrix 30 mg DRUG Phase PHASE1 Healthy Subjects COMPLETED NCT03443960
TNX-102 SL 5.6 mg DRUG Phase PHASE1 Healthy Subjects COMPLETED NCT03443960
SAN007 Cream DRUG Phase PHASE2 Atopic Dermatitis WITHDRAWN NCT03000595
SAN021 Placebo DRUG Phase PHASE2 Plaque Psoriasis WITHDRAWN NCT02993328
SAN021 Serum DRUG Phase PHASE2 Plaque Psoriasis WITHDRAWN NCT02993328
SAN007 10% cream DRUG Phase PHASE2 Atopic Dermatitis COMPLETED NCT02871479
SAN007 5% cream DRUG Phase PHASE2 Atopic Dermatitis COMPLETED NCT02871479
Treatment C DRUG Phase PHASE1 Healthy COMPLETED NCT01490788
Treatment B DRUG Phase PHASE1 Healthy Adults COMPLETED NCT03168022
Treatment A DRUG Phase PHASE1 Healthy Adults COMPLETED NCT03168022
0.25% EISO mouth rinse DRUG Phase PHASE2 Oral Mucositis COMPLETED NCT02399228
Placebo Vaginal Cream DRUG Phase PHASE3 Atrophic Vaginitis COMPLETED NCT02195986
Estrace® 0.01% cream DRUG Phase PHASE3 Atrophic Vaginitis COMPLETED NCT02195986
Estradiol Vaginal Cream, 0.01% DRUG Phase PHASE3 Atrophic Vaginitis COMPLETED NCT02195986
Bevacizumab as Avastin BIOLOGICAL Phase PHASE3 NSCLC Stage IV COMPLETED NCT04633564
Bevacizumab as MYL-1402O BIOLOGICAL Phase PHASE3 NSCLC Stage IV COMPLETED NCT04633564
Usual Care OTHER Phase PHASE2 Cocaine Intoxication WITHDRAWN NCT04996056
TNX-1300 DRUG Phase PHASE2 Cocaine Intoxication WITHDRAWN NCT04996056
MYL-1701P, a proposed biosimilar to Eylea BIOLOGICAL Phase PHASE3 Diabetic Macular Edema COMPLETED NCT04674800
Albuterol Inhalation Aerosol (short-acting beta-agonists) & Ipratropium Aerosol (short-acting anticholinergic) DRUG Phase PHASE4 COPD Exacerbation UNKNOWN NCT04655170
Revefenacin (YUPELRI) & Formoterol (Perforomist) DRUG Phase PHASE4 COPD Exacerbation UNKNOWN NCT04655170
Eylea DRUG Phase PHASE3 Diabetic Macular Edema COMPLETED NCT03610646
MYL-1701P DRUG Phase PHASE3 Diabetic Macular Edema COMPLETED NCT03610646
Enzalutamide DRUG Phase PHASE3 Prostate Cancer TERMINATED NCT02438007
Galeterone DRUG Phase PHASE3 Prostate Cancer TERMINATED NCT02438007
galeterone DRUG Phase PHASE2 Prostate Cancer TERMINATED NCT01709734
Xanax XR® Tablets 3 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00650299
Alprazolam Extended-release Tablets 3 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00650299
Glucophage® XR Tablets 500 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00650312
Zaroloxyn® Tablets 10 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00650195
Metolazone Tablets 10 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00650195
Zyrtec® Tablets 10 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00650065
Provigil® Tablets 200 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00650286
Modafinil Tablets 200 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00650286
VoSpire® ER Tablets 8 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649987
Albuterol Sulfate Extended-Release Tablets 8 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649987
Glucophage XR 500 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649948
Zithromax® Tablets 600 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00650273
Azithromycin Tablets 600 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00650273
Zyrtec® 10 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649857
Cetirizine HCl Tablets 10 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00650065
Ativan Tablets 2 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649818
Lorazepam Tablets 2 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649818
Cipro® XR Tablets 1000 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649662
Ciprofloxacin Extended-Release Tablets 1000 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649662
Prozac Pulvules 40 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649636
Fluoxetine Capsules 40 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649636
Doxycycline Monohydrate Tablets (100 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649571
Macrodantin® 100 mg Capsules DRUG Phase PHASE1 Healthy COMPLETED NCT00649506
Nitrofurantoin Macrocrystals 100 mg Capsules DRUG Phase PHASE1 Healthy COMPLETED NCT00649506
COLAZAL® Capsules 750 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649480
BALSALAZIDE DISODIUM CAPSULES, 750 MG DRUG Phase PHASE1 Healthy COMPLETED NCT00649480
Lotrel® Capsules 10 mg/20 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649519
Amlodipine and Benazepril HCl Capsules 10 mg/20 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649519
Glucophage XR 750 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649350
Hydrochlorothiazide Tablets (50 mg DRUG Phase EARLY_PHASE1 Healthy COMPLETED NCT00649324
Hydrochlorothiazide Tablets 50 mg DRUG Phase EARLY_PHASE1 Healthy COMPLETED NCT00649324
Macrobid® Capsules 100 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649285
Nitrofurantoin Monohydrate/Macrocrystals Capsules 100 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649285
Ditropan XL® Extended-release tablets, 15 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649272
Oxybutynin Chloride Extended-Release Tablets, 15 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649272
Lopressor HCT® Tablets 100/50 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649688
Metoprolol Tartrate/Hydrochlorothiazide Tablets 100/50 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649688
Aciphex® Tablets 20 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649194
Zaroloxyn® Tablets 5 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649181
Metolazone Tablets 5 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649181
Parlodel® (bromocriptine mesylate) capsules, USP 5 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649168
BROMOCRIPTINE MESYLATE CAPSULES, USP 5 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649168
Cipro® XR Tablets (500 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649155
Ciprofloxacin Extended-Release Tablets 500 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649155
Ditropan XL® Tablets 10 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649259
Oxybutynin Chloride ER Tablets 10 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649259
Accupril® Tablets 40 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649649
Quinapril Hydrochloride Tablets 40 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649649
Mobic® Tablets 15 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649675
Meloxicam Tablets 15 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649675
Zaroloxyn® Tablets 2.5 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649051
Metolazone Tablets 2.5 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649051
Lotensin HCT® Tablets 20 mg/25 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649597
Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649597
Actos® Tablets 45 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649558
Pioglitazone HCl Tablets 45 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649558
Plavix® Tablets 75 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00650169
Clopidogrel Bisulfate Tablets 75 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00650169
SYNTHROID® 300 mcg Tablets DRUG Phase PHASE1 Healthy COMPLETED NCT00648882
LEVOTHYROXINE SODIUM TABLETS, DRUG Phase PHASE1 Healthy COMPLETED NCT00648882
Zoloft® Tablets 100 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00648856
Sertraline Hydrochloride Tablets 100 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00648856
Ditropan XL® Tablets 5 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00648843
Oxybutynin Chloride Extended-release Tablets 5 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00648843
Clarithromycin DRUG Phase PHASE1 Healthy COMPLETED NCT00648830
Zofran ODT® Tablets 8 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649363
Ondansetron Orally Disintegrating Tablets 8 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649363
Proscar Tablets 5 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00648791
Finasteride Tablets 5 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00648791
Loxitane® Capsules 25 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00648778
Loxapine Succinate Capsules 25 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00648778
Levothroid® Tablets 300 μg DRUG Phase PHASE1 Healthy COMPLETED NCT00648700
Lexapro® Tablets 20 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00648661
Coreg® Tablets 12.5 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00648622
Carvedilol Tablets 12.5 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00648622
Zofran® Tablets 24 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649532
Ondansetron Tablets 24 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649532
Lexapro® Tablets (20 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00648570
Escitalopram Oxalate Tablets 20 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00648661
Synthroid Tablets 200 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00648557
Levothyroxine Sodium Tablets 200 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00648557
Pravastatin DRUG Phase PHASE1 Therapeutic Equivalency COMPLETED NCT00650221
Colazal® Capsules 750 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00648531
Balsalazide Disodium Capsules 750 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00648531
Glucophage® XR Tablets 750 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00648518
Metformin Hydrochloride ER Tablets 750 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649350
Metaglip® Tablets 5 mg/500 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649454
Glipizide and Metformin HCl Tablets 5 mg/500 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649454
Glucophage® XR 500 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00648492
Metformin Hydrochloride ER Tablets 500 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00650312
ProAmatine® Tablets 5 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00648440
Midodrine HCl Tablets 5 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00648440
Amaryl® Tablets 1 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00648362
Glimepiride Tablets 1 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00648362
Aciphex® Delayed-Release Tablets 20 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00648349
Rabeprazole Sodium Delayed-Release Tablets 20 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649194
Purinethol® Tablets 50 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00648336
Mercaptopurine 50 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00648336
Paxil® 40 mg Table DRUG Phase EARLY_PHASE1 Healthy COMPLETED NCT00648193
Paroxetine hydrochloride 40 mg tablet DRUG Phase EARLY_PHASE1 Healthy COMPLETED NCT00648193
Adoxa Tablets 100 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649571
Doxycycline Monohydrate Tablets 100 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00648180
Verelan® PM Extended-Release Capsules, 300 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649805
Verapamil Hydrochloride Extended-Release Capsules, 300 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649805
Agrylin® Capsules 1 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00648765
Anagrelide Hydrochloride Capsules 1 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00648765
Accuretic™ Tablets 20 mg/25 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649441
Quinapril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649441
Allegra® Tablets 180 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649376
Fexofenadine Tablets 180 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00649376
Adoxa Tablets 150 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00647959
Doxycycline Tablets, 150mg DRUG Phase PHASE1 Healthy COMPLETED NCT00647959
Xanax XR Tablets 1 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00647894
Alprazolam Extended-Release Tablets 1 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00647894
Paxil CR™ Tablets 25 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00648427
Paroxetine Hydrochloride Controlled-Release Tablets 25 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00648427
Synthroid® Tablets 300 μg DRUG Phase PHASE1 Healthy COMPLETED NCT00647855
Levothyroxine Sodium Tablets 300 μg DRUG Phase PHASE1 Healthy COMPLETED NCT00648700
Zyprexa® Tablets 5 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00648921
Olanzapine Tablets 5 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00648921
Lamictal® Tablets 25 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00650208
Lamotrigine Tablets 25 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00650208
Baclofen DRUG Phase PHASE1 Healthy COMPLETED NCT00647738
Xanax XR® Tablets (3 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00647634
Alprazolam Extended-Release Tablets 3 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00647634
Dilantin® Kapseals® 100 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00647621
Extended Phenytoin Sodium Capsules 100 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00647621
Inderal® LA Capsules 160 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00647816
Propranolol Hydrochloride Extended-Release Capsules 160 mg DRUG Phase PHASE1 Healthy COMPLETED NCT00647816
Timolol Maleate Gel+Placebo DRUG Phase PHASE2 Infantile Hemangioma COMPLETED NCT06677853
MR-130A-01 Transdermal patch DRUG Phase PHASE2 Contraception COMPLETED NCT06048536
TNX-102 SL Tablet, 5.6 mg DRUG Phase PHASE3 Fibromyalgia COMPLETED NCT05273749
Placebo SL Tablets DRUG Phase PHASE3 PTSD TERMINATED NCT03841773
0.5% TM DRUG Phase PHASE1 Healthy Subjects COMPLETED NCT06813807
TNX-102 SL Tablet, 2.8mg DRUG Phase PHASE3 Fibromyalgia COMPLETED NCT02436096
Timolol Maleate Gel DRUG Phase PHASE2 Infantile Hemangioma COMPLETED NCT06677853
TNX-601 ER DRUG Phase PHASE2 Depression COMPLETED NCT05686408
TNX-102 SL Tablet 2.8 mg DRUG Phase PHASE3 Primary Fibromyalgia COMPLETED NCT02589275
Placebo SL Tablet DRUG Phase PHASE3 Fibromyalgia COMPLETED NCT04172831
TNX-102 SL Tablet, 2.8 mg DRUG Phase PHASE3 Fibromyalgia TERMINATED NCT02829814
Imaging procedure to measure the distribution of a newly developed radiolabeled ligand for the oxytocin receptor DRUG Phase EARLY_PHASE1 Pain, Face COMPLETED NCT06955650
Cyclobenzaprine HCl DRUG Phase PHASE2 Acute Stress Reaction RECRUITING NCT06636786
Placebo DRUG Phase PHASE3 Seasonal Allergic Rhinitis COMPLETED NCT01293201
Intranasal Oxytocin (IN-OXT) DRUG Phase PHASE1 Vasopressin Deficiency RECRUITING NCT04789148
AO-252 DRUG Phase PHASE1 Solid Tumor Malignancies RECRUITING NCT06136884
Inert lactose placebo DRUG Phase PHASE3 Type 1 Diabetes Mellitus ACTIVE_NOT_RECRUITING NCT01320345
Fenofibrate DRUG Phase PHASE3 Type 1 Diabetes Mellitus ACTIVE_NOT_RECRUITING NCT01320345
MR-130A-01 contraceptive transdermal patch, containing norelgestromin (NGMN) DRUG Phase PHASE2 Contraception RECRUITING NCT07365904
TNX-102 SL Tablet DRUG Phase PHASE1 Pharmakokinetic ACTIVE_NOT_RECRUITING NCT07413367
Transdermal system containing progestin DRUG Phase PHASE3 Female Contraception RECRUITING NCT06672016
Kidney Transplant PROCEDURE Phase PHASE2 Kidney Transplant NOT_YET_RECRUITING NCT07204080
TNX-102 SL DRUG Phase PHASE3 Primary Fibromyalgia COMPLETED NCT02015234
Keyhole Limpet Hemocyanin (KLH) BIOLOGICAL Phase PHASE1 Phase 1 First-in-human Study Involving Healthy Subjects COMPLETED NCT07473752
Placebo: USP 0.9% sterile saline for injection DRUG Phase PHASE1 Phase 1 First-in-human Study Involving Healthy Subjects COMPLETED NCT07473752
TNX-1500 DRUG Phase PHASE2 Kidney Transplant NOT_YET_RECRUITING NCT07204080
Total products: 220